In response to severe stress, apoptotic cell death is engaged. Apoptosis is a wellorchestrated process that involves the activation and implication of many factors. In this study, we identify a role for the nuclear trafficking factor Transportin 2 (TRN2) in cell death. TRN2 is normally responsible for the nuclear import of the RNA-binding protein HuR. During apoptosis, however, HuR accumulates in the cytoplasm. This is due to the caspase-mediated cleavage of the cytoplasmic fraction of HuR. One of the cleavage fragments generated by this processing of HuR interacts with TRN2 and thus blocks the re-import of HuR into the nucleus. This concentrates HuR in the cytoplasm, advancing apoptosis. Therefore, increasing or decreasing the levels of TRN2 has an inverse consequential effect on cell death, demonstrating for the first time the role of a nucleocytoplasmic transport factor in apoptosis.
When confronted with stress, eukaryotic cells undergo different responses dependent on the severity and duration of the stress (1) . While adaptation and survival are at one end of these responses, cellular death can also be the outcome. Apoptotic cell death is a complex pathway involving the activation and cleavage of several proteins, some of the most important of which are cysteine aspartic proteases (caspases). This family of proteases then cleaves specific substrates, allowing the progression of cell death (2) (3) (4) (5) . These caspase-targets may be cleaved in order to cause the organized destruction of a cell, but it can also serve to activate target proteins that have important roles in advancing apoptosis themselves. Recently, the RNA-binding protein HuR was identified as one such protein (6) . Under normal conditions, HuR is an important regulator of gene expression, controlling the localization, stabilization and translation of many different mRNAs (7, 8) . The targets of HuR are involved in many cellular processes including cell growth, differentiation, survival, and apoptotic cell death. Likewise, the importance of HuR in regulating these processes has been shown, given that its absence or overexpression in different systems can have potent effects on cell physiology (6, (9) (10) (11) (12) .
The role of HuR a promoter of cell death was identified when it was found that caspases-3 and -7 cleave HuR in response to lethal stress (6) , such as with the use of the apoptotic stimulator drug staurosporine (STS). The cleavage of HuR, occurring at the D226 residue of this protein, yields two cleavage products: HuR-CP1 (26kDa) and -CP2 (8kDa). Mutation of this cleavage site prevents apoptosis, while providing these two cleavage products can stimulate cell death in non-lethal conditions (13) . It was shown that HuR-CP2 helps promote apoptosis by binding to PHAPI (6) , an activator of apoptosis and a known ligand of full-length HuR. The implication of other protein partners, however, has not yet been explored.
Intriguingly, prior to its cleavage, HuR, which typically shuttles between the nucleus and the cytoplasm, must have an increased cytoplasmic localization. We previously observed that this occurs as soon as one hour following STS-treatment, whereas HuR cleavage only appears on a western blot after 1.5-2 hours (6). Furthermore, while only ~10% of total HuR is cleaved during stress (6), this is roughly 50% of the total percentage of HuR found in the cytoplasm (22) . Similar results were also found during muscle differentiation. HuR and its cleavage are crucial for the fusion of muscle cells (myoblasts) to form fibers (myotubes) (9, 10, 14) . In a recent study, we showed that this cleavage, which also depends on caspases and occurs at D226, is also related to the cytoplasmic accumulation of HuR. Upon being cleaved, HuR-CP1 competes with full-length HuR for binding with its import factor Transportin 2 (TRN2) (14, 15) . TRN2 was previously shown to promote the nuclear import of HuR (16, 17) , and in our muscle differentiation study, we saw that by binding TRN2, HuR-CP1 prevents the nuclear reuptake of HuR, thus causing it to accumulate in the cytoplasm (14) . The consequence of this is that HuR may perform its post-transcripational regulatory functions, and have a greater portion of it cleaved.
These data have raised the possibility that a similar mechanism may be taking place during stress response. The region of HuR previously shown to associate with TRN2, the HuR nucleocytoplasmic shuttling (HNS) domain (16) (17) (18) , is in fact the location of the D226 caspase-cleavage site of HuR (6, 14) . This further supports that the cleavage of HuR may interfere with the normal localization and nuclear import of HuR during apoptosis. Therefore, in this study we investigated the role of TRN2 in regulating HuR cleavage, and also if TRN2 itself contributes to the apoptotic response.
EXPERIMENTAL PROCEDURES
Cell culture, transfections and treatmentsHeLa CCL-2 cells (ATCC) were grown and maintained in L-glutamine-containing DME medium (Sigma-Aldrich) which was supplemented with fetal bovine serum (10%) and penicillin/streptomycin (SigmaAldrich). Plasmids (described below) and siRNA duplexes [Control (9), siRNA-HuR (9) and siRNA-TRN2 (15)] were transfected when cells were at approximately 70% confluency (for plasmid transfections) or 50% confluency (for siRNA transfections), as previously described. When transfecting cells with siTRN2, this transfection was repeated 24 hours following the first transfection. In all cases, samples were harvested 48h following transfections. Lipofectamine and PLUS reagents (Invitrogen) were used according to the manufacturer's description. Staurosporine (STS; Sigma-Aldrich) was used at 1µM concentration for 3 hours to induce cell death, as previously described (6) .
Immunofluorescence and quantification of nuclear fragmentation-HeLa cells, plated on cover-slips, were treated as described in figure legends. Cells were fixed and immunofluorescence was performed as described (19) . Monoclonal anti-HuR antibody [3A2; (20) ], polyclonal Ras-GAP SH3 domain binding protein [G3BP; (23) ] and Alexa Fluor 488 secondary antibody (Molecular Probes) were used, along with 4',6-diamidino-2-phenylindole (DAPI) stain. Images were taken at room temperature with a 63x oil objective and using an Axiovert 200M microscope (Carl Zeiss Inc.) as previously described (6) . In order to determine nuclear fragmentation, pictures of 10 fields per condition where taken, and the sum of all fragmented nuclei in these fields was divided by the sum of all nuclei (whole and fragmented) in the same fields.
Cellular
fractionation, cell extract preparation, and western blottingCytoplasmic and nuclear fractions, along with total cell extracts, were prepared as previously described (13, 21) . Western blotting, performed as described (22) , used the following antibodies: HuR [3A2; (20) ], hnRNP A1, cleaved caspase-3, caspase-7 (Cell Signaling), Flag (Sigma-Aldrich), α -tubulin (Developmental Studies Hybridoma Bank), G3BP (23) and GFP (which also recognizes CFP; Clontech). Quantification of bands in western or slot blots was done using ImageQuant software as described in figure legends. Statistical analysis for significance was performed using online GraphPad software, with a two-tailed, unpaired t-test.
RNA isolation and slot blot-Cells were collected in Trizol (Invitrogen) and mRNA was isolated as described according to the manufacturer's protocol. RNA was then loaded onto a slot blot and analyzed as described (19) , using radiolabeled probes complementary to TRN2 and 18S RNA as previously described (15,24).
Immunoprecipitation-HeLa cells were treated as detailed in the figure legend and collected. Immunoprecipitation protocol was performed as previously described (14) using Protein A beads (GE Healthcare) and with anti-TRN2 (15) or IgG control antibodies (Jackson ImmunoResearch Laboratories).
Plasmid construction-GFP, GFP-HuR and GFP-HuR-CP1 plasmids were previously described (6, 13) . CFP-TRN2 plasmid was generated as previously described, except that here CFP-containing pcDNA3 (generously donated by J. Pelletier) was used in place of YFP-containing plasmid (14) . The primers used were the same as previously published. Flag-HuR-CP1 and Flag-HuR-CP2 plasmids were generated by PCR amplification of GFP-HuR plasmid as a template, using the following primers. The forward primers used also contained a sequence to produce a Flag-tag at the 5' end of the proteins. Primers: Flag-CP1-F: 5'-ccg gaa ttc atg gac tac aaa gac gac gac gac aaa tct aat ggt tat gaa gac cac-3' ; Flag-CP1-R: 5'-taa agc ggc cgc tta atc gac gcc cat ggg gga-3'; Flag-CP2-F: 5'-ccg gaa ttc atg gac tac aaa gac gac gac gac aaa cac atg agc ggg ctc tct-3' ; Flag-CP2-R: 5'-gaa agc ggc cgc tta ttt gtg gga ctt gtt ggt ttt-3'.
For both HuR-CP1 and HuR-CP2 amplification, this created an EcoRI/NotI PCR product which was restriction digested and ligated into pcDNA3 plasmid (Invitrogen).
RESULTS

Transportin 2 regulates HuR localization and cleavage.
To investigate if there is a link between TRN2 and the cytoplasmic accumulation of HuR during apoptosis, we first depleted TRN2 expression and followed HuR localization. We observed that the knockdown of TRN2 (siTRN2), compared to control siRNA (siC) ( Figures  1A-B) , resulted in an increase in the portion of HuR which could be found in the cytoplasm ( Figures 1C-E) . This was seen both visually by performing immunofluorescent staining (IF) against HuR ( Figure 1C) , and also by isolating out the nuclear and cytoplasmic fractions of transfected cells and looking at the amount of HuR present in each fraction (Figures 1D-E). These data suggest that in HeLa cells, TRN2 regulates the nuclear-localization of HuR seen in normal conditions. This does not evaluate, however, the implication of TRN2 in stress response.
To determine if TRN2 is involved in apoptosis, knockdown of its expression was repeated, and cells were then treated or not with STS to induce death. The reduction of TRN2 under these conditions resulted in a significant increase in the fragmentation of cellular nuclei, as seen by performing DAPI staining on fixed cells (Supplemental Figure  1 ; Figure 2A ). During apoptosis, nuclei condense to become smaller, and then fragment as the cells die, and so quantification of the percentage of cells with fragmented nuclei is a reflection of the apoptotic state of the population (6) . Additionally, the cleavage of caspase-3, an important caspase and a known marker of apoptosis (5) was assessed and quantified ( Figures 2B-C) . Both of these measures of apoptosis indicated that a reduction of TRN2 expression increased the apoptotic response to STS. When TRN2 was overexpressed by transfecting a cyan fluorescent protein (CFP)-tagged TRN2 plasmid into HeLa cells, and these were later treated with STS, the opposite response was observed ( Figures  2E-G) .
In this situation, nuclear fragmentation and caspase-3 cleavage significantly increase. Intriguingly, in both the reduction and overexpression of TRN2, HuR cleavage also changed (Figures 2B, D, F and H), similarly to caspase-3 cleavage. This raised the possibility that modifying TRN2 expression may depend on HuR cleavage. Conversely, since HuR was identified as a target of caspase-3, the changes observed in HuR cleavage may simply be secondary. To determine whether this was the case or not, TRN2 and HuR were knocked down simultaneously, to assess whether TRN2 knockdown would still promote apoptosis in the absence of HuR ( Figure 3 ). As expected (6), cell death was reduced in the absence of HuR (determined by caspase-3 cleavage [ Figures  3A-B] and percentage of fragmented nuclei [ Figure 3C ]). Importantly, the significant increase in caspase-3 cleavage and nuclear fragmentation which occurs during knockdown of TRN2 was lost in cells depleted of endogenous HuR (Figures 3A, compare lanes 5 and 6 to 7 and 8, and 3C). This supports that it is through HuR cleavage that TRN2 is regulating apoptosis, and that the observed changes in the level of caspase-3 cleavage and nuclear fragmentation following knockdown and overexpression of TRN2 are a consequence of this regulation.
HuR-CP1 binds with Transportin 2 to promote apoptosis. The observations described above identified a role for TRN2 in regulating apoptosis. A role for TRN2 in stress response was previously proposed when we showed that the interaction between HuR and TRN2 is lost following heat shock (18) , but the mechanism behind this effect was not determined. To better understand how TRN2, through HuR cleavage, is implicated in stress response and cell death, we wished to determine if the HuR/TRN2 interaction in HeLa cells would also change following STS-treatment. HeLa cells were treated or not with STS and an immunoprecipitation was performed using anti-TRN2 antibody, to evaluate the association of HuR with this transport factor ( Figure 4 ). As expected, HuR interacted with TRN2, but in response to STS, this interaction was reduced (compare lane 6 to 8). A similar change in HuR/TRN2 association was reported to occur during muscle differentiation (15). It was later shown that this dissociation is due to an interaction between TRN2 and the larger HuR cleavage product, HuR-CP1 (14) . HuR-CP1 was actually shown in vitro to outcompete with HuR for binding to TRN2, while HuR-CP2 has no effect [See Figure 5d of (14)]. These data raise the possibility that in our apoptotic system, HuR-CP1 may be playing a similar role.
If HuR-CP1 is indeed binding to TRN2 and thus causing HuR to accumulate in the cytoplasm in HeLa cells undergoing apoptosis, expressing this cleavage product should cause accumulation of full-length HuR in the cytoplasm. To determine if this is the case, we wished to see if HuR-CP1 could affect the localization of HuR. Since our monoclonal anti-HuR antibody (3A2) recognizes the N-terminus of HuR protein, it is incapable of distinguishing between fulllength HuR and HuR-CP1 in an IF experiment. Therefore, GFP-tagged HuR was co-transfected into HeLa cells with either empty pcDNA3 vector, or Flag-tagged HuR-CP1 or -CP2 plasmids ( Figure 5A ). The localization of full-length HuR was monitored in these cells by fluorescence microscopy ( Figure 5B) , and it was seen that Flag-HuR-CP1 caused significantly more cells to have HuR in the cytoplasmic compartment (co-staining with G3BP, a cytoplasmic marker) than either HuR-CP2 or empty plasmid (Figures 5B-C) . Since both TRN2 knockdown and HuR-CP1 overexpression (Figures 1, 5 ) caused an increase in the portion of HuR that is found in the cytoplasm similarly to lethal stress treatment (6) , this supports our hypothesis that TRN2 and HuR-CP1 are working together to coordinate this effect.
If TRN2 actually affects apoptosis by regulating the localization and cleavage of HuR, then it should be possible to negate the inhibitory effect of overexpressing TRN2 on apoptosis by providing HuR-CP1. CFP-TRN2 and GFP-HuR-CP1 (or CFP and GFP as respective controls) were co-transfected into HeLa cells. 48 hours following these transfections, cells were treated with STS and caspase-3 cleavage was evaluated by western blot as an indicator of cell death ( Figures 6A-B) . Nuclear fragmentation was also determined, as described above ( Figure  6C ). As expected, overexpression of TRN2 caused a decrease in both the cleavage of caspase-3 and fragmentation of nuclei ( Figures 6A, compare lanes 1 to 2, and 6C) , but in the presence of HuR-CP1, these decreases are lost (compare lanes 3 to 4). Together, these results clearly show that the role of TRN2 in cell death is linked to its regulation of HuR localization and cleavage.
DISCUSSION
TRN2 was previously implicated in regulating HuR localization in both HeLa and C2C12 muscle cells (15-17). It was later found that TRN2 plays an important role during the process of muscle differentiation, where the cytoplasmic accumulation and caspase-mediated cleavage of HuR are necessary (14) . This is achieved by having HuR-CP1 bind to TRN2 and causing a failure in the nuclear import of full-length HuR. Thus, HuR moves out of the nucleus, but fails to return, concentrating it in the cytoplasmic compartment. In this study we have found that a similar mechanism is taking place following response to lethal stress. HuR is cleaved by caspases in the cytoplasm, and the HuR-CP1 fragment that is generated interferes with the TRN2-mediated import of HuR back into the nucleus.
Data presented here (Figure 2) demonstrates that TRN2 is also involved in apoptosis. When TRN2 levels are modified during stress response, caspase-3 levels and the fragmentation state of nuclei are altered, suggesting that TRN2 is an anti-apoptotic factor. By showing that this effect is dependent on HuR, and can be negated by the presence of HuR-CP1 however ( Figures  3, 6 ), we demonstrate that the role of TRN2 in cell death is actually a consequence of the pro-apoptotic cleavage of HuR. Recently, Protein Kinase RNA (PKR) was also linked to regulating HuR cleavage during stress response (13) . PKR has been heavily implicated in cell death, however, while this is the first time that a transport factor is linked to regulating this process. Together, this study and the results reported in this manuscript have revealed added complexity to the apoptotic cascades occurring in response to lethal stimuli. Unlike PKR which is involved in many cellular pathways (25) , there have been only limited functions and partners identified for TRN2. Our data thus suggest that TRN2 levels could be modulated to influence cell fate. The fact that cell death can be affected by modifying the cytoplasmic accumulation of HuR as shown here suggests that clinical induction of apoptosis could be achieved, or facilitated, by blocking the HuR/TRN2 interaction.
The smaller cleavage fragment of HuR, HuR-CP2, is capable of interacting with the pro-apoptotic protein partner of HuR, PHAPI (6) . PHAPI itself is also linked with HuR localization, as PHAPI contains both a nuclear export signal (NES), and is essential for the cytoplasmic accumulation of HuR during stress response (6, 18, 26) . We previously showed that the association between HuR and PHAPI is mediated through the HNS and 3 rd RNA-recognition motif (RRM3) of HuR, while the HNS was also shown to be necessary for the HuR/TRN2 interaction (18, 22) . Intriguingly, while PHAPI associates with RRM3-containing HuR-CP2, only a portion of the HNS is part of this second HuR-CP. The bulk of the HNS remains within HuR-CP1 however, which we showed can interact with TRN2 to even a greater extent than full-length HuR (14) . On the other hand, HuR-CP2 neither interacts with TRN2 (14) , nor does it affect the localization of HuR (Figures 5B-C) . Collectively, these data support that through its caspase-cleavage, HuR can alter its interaction with protein partners, possibly by providing better binding specificity with its ligands for its CPs, rather than full-length HuR. This also raises the possibility that HuR-CPs can interact with protein partners that do not associate with full-length HuR. This may explain how the presence of these two cleavage products can trigger cell death in non-lethal conditions (13 (6) . One explanation for this is that some HuR cleavage occurs early on following lethal stress. While not detectable by western blot, this low amount of HuR-CPs that are generated may cause cytoplasmic accumulation of HuR (-CP1) and activation of the apoptosome (-CP2), then capable of cleaving more HuR. This feedback-loop mechanism was originally proposed upon the discovery of HuR cleavage (6) , and is supported by the observations in this manuscript. Intriguingly, the inhibition of caspases by zVAD in our previous study did not appear to prevent the cytoplasmic localization of HuR after 3 hours of STS. Since some cleavage of HuR could be seen at that late time point, however, it is possible that this effect is due to the generation of some HuR-CP1, capable of binding TRN2. Of course, there is also the possibility that another unknown mechanism (such as a posttranslational modification or competing factor) may influence the association between HuR and TRN2, prior to HuR-CP1 production. In this case the HuR-CP1 could enhance the cytoplasmic accumulation of HuR that began prior to its appearance. Further studies on TRN2 ligands and its modifications, in both untreated and stress response conditions, will help explore this possibility.
HuR is the best-studied stabilizer of mRNA, and has important roles in regulating the localization, translation, and stability of its targets, thus having substantial ability to impact gene expression. HuR functions can be modulated by alterations such as the cleavage or localization of HuR itself however, and upon the discoveries of such mechanisms, reconsideration of HuR function is required. Here we show that the TRN2-mediated localization of HuR during stress response is important for its proapoptotic role. This also implicates TRN2 in cell death, demonstrating that the ubiquitously-expressed RNA-binding protein HuR can have extensive control over not only gene expression, but also protein function. award. This work was supported by an NCIC operating grant (016247) and a CIHR (MOP-89798) operating grant to IEG. IEG is a recipient of a TierII Canada Research Chair. Figure 1 : Transportin 2 regulates the nuclear localization of HuR (A-B) siTRN2 reduces the level of TRN2 RNA. HeLa cells were transfected with either a siRNA that targets TRN2 or control siRNA (siC). Their total RNA content was isolated and analyzed by slot blot, probing for TRN2 and 18S (loading control). Quantification was performed using ImageQuant software, and average values of TRN2 levels, relative to 18S, is graphed in (B), with error bars representing the SEM of four independent experiments. The asterisk denotes that the observed difference is significant, with P=0.0006. (C-E) Knockdown of TRN2 causes HuR to accumulate in the cytoplasm. Cells were treated as described in (A). They were fixed and immunofluorescence was performed, by staining with anti-HuR antibody and DAPI (C). Bars represent 20µm. Alternatively, total content of lysed cells was separated into nuclear and cytoplasmic fractions, and analyzed by western blot (D), with antibodies against HuR, hnRNP A1 (nuclear marker), and α-tubulin (cytoplasmic marker). Quantification of HuR and α-tubulin band intensities was determined using Image Quant software, and average values of cytoplasmic HuR levels, relative to α -tubulin, is graphed in (E), with error bars representing the standard error of the mean (SEM) of three independent experiments. The asterisk denotes that the observed difference is significant, with P=0.0053. All images shown (C) and the blot (D) are representative of three independent experiments. Figure 1 , and 48 hours after transfection, they were treated for 3 hours with 1µM of staurosporine (STS). Cells were then fixed and stained with DAPI, a nuclear fluorescent marker, and images were then taken. 10 fields per condition were used to determine the percentage of cells in which nuclei appeared fragmented. Average percentages were graphed with error bars representing the SEM of three independent experiments. The asterisk denotes that the observed difference is significant, with P=0. 0093. (B-D) Knockdown of TRN2 results in an increase in the cleavage of caspase-3 and HuR. Cells treated as in (A) were collected after STS-treatment and their lysates were analyzed by western blot (B), using antibodies against HuR, caspase-3 cleavage product (caspase-3 CP; a known marker of apoptosis), and Ras-GAP SH3 domain binding protein (G3BP; loading control). Cleavage products of caspase-3 and HuR were quantified as described in Figure 1 and average values, relative to loading control, were graphed in (C) and (D), with error bars representing the SEM of three independent experiments. The asterisks denote that the observed differences between siC-and siTRN2-treated cells are significant, with P=0.0006 for caspase-3 cleavage, and P<0.0001 for HuR cleavage. (E) STS-treatment causes a decrease in nuclei fragmentation following TRN2-overexpression. HeLa cells were transfected with plasmids encoding cyan fluorescent protein (CFP) or a CFP-tagged TRN2, and were treated with STS as described for (A). Cells were then fixed and stained as in (A), and quantification of 10 fields per condition for three independent experiments was also done as in (A). The average percentages of cells with fragmented nuclei were graphed, with error bars represent the SEM of three independent experiments, and the asterisk indicates that the observed difference is significant, with P=0.0040. (F-H) Overexpression of TRN2 causes a decrease in the cleavage of caspase-3 and HuR. Total cell lysates were prepared from samples treated as in (E) and were analyzed by western blot using antibodies against CFP, cleaved caspase-3, HuR and G3BP (loading control). Quantifications of cleavage products was performed as described above and are shown in (G) and (H), with error bars representing the SEM of three independent experiments. Asterisks show that the observed differences are significant with P=0.0053 for caspase-3 cleavage and P=0.0001 for HuR cleavage. Figure 2A and analyzed by western blot (A-B) using antibodies against HuR, cleaved caspase-3 and G3BP (loading control), or by microscopy with DAPI stain (C). Quantification of caspase-3 cleavage was performed as in Figure 2 and graphed in (B). Images were taken of DAPI-stained samples, and 10 fields were used for each condition so that the percentage of cells with fragmented nuclei could be assessed, and average percentages of three independent experiments were graphed (C). Error bars (B, C) indicate the SEM of three independent experiments, and the asterisks indicate that the observed differences are significant, with P=0.0131 and P=0.0365 for (B) and (C), respectively, whereas non-significant differences are indicated by "NS". Lysates from these cells were prepared and analyzed by western blot 48 hours after transfection, using anti-Flag and anti-GFP antibodies (A), or cells were fixed and immunofluorescence was performed using anti-G3BP antibody (a cytoplasmic marker), along with DAPI stain (B). Bars represent 20µm, and arrows indicate cells where GFP-HuR was seen in the cytoplasm. The number of cells which contained GFP-HuR in 12 fields per condition were counted, and the number of cells in which GFP-HuR was found in the cytoplasm was determined. Average percentages from five independent experiments were graphed (C) with error bars representing the SEM of these five independent experiments, a representative field of which is shown in (B). The asterisks denote that the observed differences are significant, with P<0.0001 when comparing pcDNA3 and Flag-HuR-CP1, and P=0.0005 between Flag-HuR-CP1 and -CP2. (A-C) HeLa cells were co-transfected with either a plasmid containing GFP or GFP-tagged HuR-CP1, and either CFP or CFP-TRN2. 48 hours following this transfection, cells were treated with 1µM STS for 3 hours and collected or fixed. Lysates were analyzed by western blot using antibodies against GFP/CFP (both are recognized), cleaved caspase-3 and G3BP (loading control), a representative blot of which is shown (A). The relative levels of cleaved caspase-3 were determined and normalized to loading controls as described above, and average values were graphed in (B) with error bars representing the SEM of at least three independent experiments. Alternatively, fixed cells were stained with DAPI and 10 images were taken per condition, which allowed the percentage of cells in which nuclei were fragmented to be determined. The average percentages of cells with fragmented nuclei of three independent experiments are graphed in (C), with error bars representing the SEM of three independent experiments. Asterisks indicate significant differences with P=0.0085 for (B) and P=0.0105 for (C), and "NS" indicates not statistically significant differences. 
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